Clinical trials
Phase 2 Lung Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2006 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 4 |
| Withdrawn | 4 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 7 |
| Novartis Pharmaceuticals | 4 |
| Pfizer | 2 |
| Actuate Therapeutics Inc. | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Astellas Pharma Inc | 1 |
| Daiichi Pharmaceuticals | 1 |
| Daiichi Sankyo | 1 |
| Dutch Society of Physicians for Pulmonology and Tuberculosis | 1 |
| Eli Lilly and Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 31 |
| Carcinoma, Non-Small-Cell Lung | 19 |
| Adenocarcinoma of Lung | 4 |
| Breast Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Melanoma | 2 |
| Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Stomach Neoplasms | 2 |
| Bone Neoplasms | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.